| Identification | Back Directory | [Name]
RA VII | [CAS]
86229-97-2 | [Synonyms]
RA VII
Methylether of TPC-A
Cyclo(D-alanyl-L-alanyl-N,O-dimethyl-L-tyrosyl-L-alanyl-N-methyl-L-tyrosyl-3-hydroxy-N,O-dimethyl-L-tyrosyl), cyclic (5→6)-ether | [Molecular Formula]
C41H50N6O10 | [MDL Number]
MFCD01745053 | [MOL File]
86229-97-2.mol | [Molecular Weight]
786.878 |
| Hazard Information | Back Directory | [Uses]
RA-VII is an antitumor agent that exhibits significant activity against L1210, B-16 melanoma, Lewis lung carcinoma, Colon 38 and Ehrlich carcinoma[1]. | [References]
[1] Itokawa H, et al. Isolation and antitumor activity of cyclic hexapeptides isolated from Rubiae radix. Chem Pharm Bull (Tokyo). 1984 Jan;32(1):284-90. DOI:10.1248/cpb.32.284 |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|